Joel Sunshine M.D.

Loss of Effective Antigen Presentation in Melanoma and Treatment Failure

Loss of effective presentation of tumor antigens by melanoma may drive immunotherapy resistance. We will use multiplex immunofluorescence to map antigen presentation at single-cell resolution across whole slides, and correlate…

Read More
Wesley Yu, MD

Preventing Metastasis of High-Risk Melanoma

In the U.S., more than 7,000 people die from melanoma annually. Up to one-third of these deaths are caused by early, localized melanomas (AJCC Stage 1–2) that metastasize despite appropriate…

Read More